Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Robot-assisted procedures for neurovascular conditions

Official title: Robot-assisted Neurovascular Intervention for Patients Indicated for Angiography, Cerebral Artery Embolization, and Thrombectomy: Exploratory Study to Compare to Existing Interventional Procedures

Run by Navigantis Inc. · NCT06752096 · Data updated 2026-11-12

This study is testing whether using robots to help with brain and blood vessel procedures can make them safer and more effective for patients.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment10 (estimated)
SponsorNavigantis Inc.
Industry-sponsored
Locations1 site (Seoul, Korea)
StatusRecruiting
StartedDecember 27, 2024
Main results expectedDecember 1, 2026
Study endsDecember 2, 2026
Registry record updatedJanuary 16, 2026
Trial IDNCT06752096 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled for neurovascular interventions like cerebral angiography, embolization for meningioma, or thrombectomy for stroke.

Probably not a fit

Patients with recent surgeries, severe atheromatous disease, or certain cardiac conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the use of robotic assistance in neurovascular interventions for patients scheduled for procedures such as cerebral angiography, arterial embolization for meningioma, and thrombectomy for ischemic stroke. The aim is to evaluate the feasibility and potential advantages of performing these interventions robotically compared to traditional manual methods. Eligible patients will undergo standard selection criteria for these procedures, ensuring safety and efficacy. The study will assess outcomes related to the robotic approach in treating various neurovascular disorders.

Why it matters

Potential benefit: If successful, this approach could enhance the precision and safety of neurovascular interventions, potentially leading to better patient outcomes.

How similar studies have gone: While robotic assistance in surgery is gaining traction, this specific application in neurovascular interventions is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients scheduled for neurovascular interventions, such as diagnostic cerebral angiography for cerebrovascular diseases, arterial embolization for meningioma treatment, and thrombectomy for thrombotic arterial occlusion-induced cerebral ischemia, are selected according to the same criteria as standard cerebral angiography and interventional procedures.

Exclusion Criteria:

Exclusion Criteria 1 (General):

1. Patients who have undergone surgery within 4 weeks prior to study participation or have not fully recovered from surgery.
2. Patients who are pregnant or breastfeeding.
3. Patients with existing or anticipated vasospasm, bleeding, or severe atheromatous disease.
4. Patients allergic to contrast agents used in angiography.
5. Patients with renal failure.
6. Patients with a history of cardiac events, such as myocardial infarction or superior vena cava (SVC) syndrome, within 3 months prior to study participation, or with existing heart disease.
7. Patients unable to cooperate due to difficulty in expressing intent to the extent that the procedure cannot proceed.
8. Patients with severe or life-threatening comorbidities that could significantly affect symptom improvement or render the procedure unbeneficial.
9. Patients with non-life-threatening comorbidities that prevent proper follow-up for treatment.

Exclusion Criteria 2 (Cerebral Ischemic Stroke Patient):

1. Patients with an ASPECTS score of 0-2 on a pre-treatment non-contrast CT.
2. Inability to perform femoral puncture within 60 minutes of completing CT angiography (if CT perfusion is performed, it must be done after CT angiography).
3. Absence of a femoral pulse.
4. Cases where vascular access is highly challenging, with an anticipated time exceeding 90 minutes from CT angiography to reperfusion.
5. Patients suspected to have cerebral artery dissection or atherosclerosis as the cause of stroke.
6. Patients where the intracranial occlusion is determined to be chronic based on clinical history, prior imaging, or clinical judgment.

Where it's running

  • Severence Hospital, Yonsei University College of Medicine
    Seoul, Korea, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.